SPHK1 and cancer: SphK1 has been identified as a potential therapeutic target in cancer [14]–[18] as evidenced by two lines of investigations: (i) overexpression of Sphk1 in fibroblasts resulted in the acquisition of transformed phenotype and (ii) MCF7 cell xenografts over-expressing Sphk1 grew more rapidly in nude mice [19].